Helix BioMedix, Inc. (HXBM) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Helix BioMedix, Inc. (HXBM).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $6.45

Daily Change: -$0.73 / 11.32%

Range: $0 - $0

Market Cap: $1,449,366

Volume: 0

Performance Metrics

1 Week: -0.14%

1 Month: -0.14%

3 Months: -40.17%

6 Months: -60.66%

1 Year: -69.12%

YTD: -10.25%

Details

Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.

Selected stocks

CAB PMTS HLDGS LTD. (CABPF)

Close Brothers Group Plc (CBGPY)

Close Brothers Group Plc (CBGPF)